image
image
user-login
Patent search/

CRIZANLIZUMAB CONTAINING ANTIBODY FORMULATION

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

CRIZANLIZUMAB CONTAINING ANTIBODY FORMULATION

PCT NATIONAL PHASE APPLICATION

Published

date

Filed on 28 April 2022

Patent Information

Application ID202217024939
Date of Application28/04/2022

Documents

NameDate
202217024939-FORM 3 [09-11-2023(online)].pdf09/11/2023
202217024939-FORM 18 [26-10-2023(online)].pdf26/10/2023
202217024939-FORM 3 [04-04-2023(online)].pdf04/04/2023
202217024939-AMENDED DOCUMENTS [17-03-2023(online)].pdf17/03/2023
202217024939-FORM 13 [17-03-2023(online)].pdf17/03/2023
202217024939-FORM 3 [14-10-2022(online)].pdf14/10/2022
202217024939-Correspondence-070622.pdf11/06/2022
202217024939-Others-070622.pdf11/06/2022
202217024939-Proof of Right [26-05-2022(online)].pdf26/05/2022
202217024939-COMPLETE SPECIFICATION [28-04-2022(online)].pdf28/04/2022
202217024939-DECLARATION OF INVENTORSHIP (FORM 5) [28-04-2022(online)].pdf28/04/2022
202217024939-DRAWINGS [28-04-2022(online)].pdf28/04/2022
202217024939-FORM 1 [28-04-2022(online)].pdf28/04/2022
202217024939-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [28-04-2022(online)].pdf28/04/2022
202217024939-POWER OF AUTHORITY [28-04-2022(online)].pdf28/04/2022
202217024939-PRIORITY DOCUMENTS [28-04-2022(online)].pdf28/04/2022
202217024939-PROOF OF RIGHT [28-04-2022(online)].pdf28/04/2022
202217024939-SEQUENCE LISTING [28-04-2022(online)].txt28/04/2022
202217024939-SEQUENCE LISTING(PDF) [28-04-2022(online)].pdf28/04/2022
202217024939-STATEMENT OF UNDERTAKING (FORM 3) [28-04-2022(online)].pdf28/04/2022
earn

Refer a friend